Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial

Pierre Renaudin (1) , Karine Baumstarck (2) , Aurélie Daumas (3, 4) , Marie-Anne Esteve (5, 6, 7) , Stéphane Gayet (3) , Pascal Auquier (2) , Michel Tsimaratos (1) , Patrick Villani (1) , Stéphane Honore (5, 1, 8, 7)

1 TIMONE - Hôpital de la Timone [CHU - APHM]
2 SPMC - Santé Publique et maladies Chroniques : Qualité de vie Concepts, Usages et Limites, Déterminants
3 APHM - Assistance Publique - Hôpitaux de Marseille
4 AMU - Aix Marseille Université
5 CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie
6 Service Pharmacie [Hôpital de la Timone - APHM]
7 AMU PHARM - Aix-Marseille Université - Faculté de pharmacie
8 INSERM - Institut National de la Santé et de la Recherche Médicale

Background: Early hospital readmission of patients after discharge is a public health problem. One major cause of hospital readmission is dysfunctions in integrated pathways between community and hospital care that can cause adverse drug events. Furthermore, the French ENEIS 2 study showed that 1.3% of hospital stays originated from serious adverse drug events in 2009. Pharmacy-led medication reviews at hospital transitions are an effective means of decreasing medication discrepancies when conducted at admission or discharge. However, it is difficult to assess the true impact of pharmacist-led medication reviews in specific high-risk populations, such as pediatric and geriatric populations. In such a context, it is important to demonstrate the effectiveness of medication reconciliation as part of a standardized medication review process—in pediatric and elderly populations—on all-cause readmissions in a large randomized controlled clinical trial. The aim of this study is to assess the impact of the pharmacist-led medication review on the rate of readmissions and/or death after hospital discharge and patient treatment satisfaction.

Domains: Life Sciences [q-bio]; Human health and pathology; Life Sciences [q-bio]; Human health and pathology; Geriatry and gerontology; Life Sciences [q-bio]; Human health and pathology; Pediatrics; Life Sciences [q-bio]; Pharmaceutical sciences

Pierre Renaudin, Karine Baumstarck, Aurélie Daumas, Marie-Anne Esteve, Stéphane Gayet, et al.. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials, 2017, 11, pp.32 - 32. ⟨10.1186/s13063-017-1798-6⟩. ⟨hal-01478931⟩